The FDA has chosen Eli Lilly and Regeneron to participate in a new pilot program aimed at speeding up the development and approval of domestic drug manufacturing facilities, CNBC reports. The ini…
Already an INSIDER? Sign in.
A new FDA strategy aims to get medicines to the market faster
